Physician
Dent Neurologic Group LLP
Dent Neurologic Group LLP was paid $7.44M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoDENT NEUROLOGIC GROUP LLP
AMHERST, NY 14226
AMHERST, NY 14226
33aNPI1497850911assigned 09/13/2006
33bProvider typePsychiatry Physician
28Total paid$7.44M
24GClaims90,460
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatry Physician providers in New York
Rank by total paid#6 of 1,033
Median peer was paid$8K
This provider vs. median963×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,223 | $343K | |
| 2019 | 6,019 | $368K | |
| 2020 | 10,632 | $758K | |
| 2021 | 17,533 | $1.37M | |
| 2022 | 19,349 | $1.64M | |
| 2023 | 19,958 | $1.75M | |
| 2024incomplete | 11,746 | $1.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 40,949 | 40,385 | $3.34M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 15% | 4,264 | 4,261 | $1.11M |
| 95819 | 8.3% | 1,682 | 1,680 | $619K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.7% | 3,183 | 3,183 | $421K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3.6% | 694 | 694 | $268K |
| 99205 | Prolong outpt/office vis | 3.1% | 1,244 | 1,244 | $228K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2.2% | 1,301 | 1,300 | $166K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 3,888 | 3,487 | $158K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.1% | 1,838 | 777 | $154K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 2,401 | 1,854 | $123K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 5,337 | 5,317 | $120K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.5% | 1,017 | 931 | $114K |
41 more codes
| 20553 | 1.5% | 2,948 | $109K | |
| 95886 | 1.1% | 849 | $83K | |
| 72141 | <1% | 236 | $56K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 351 | $47K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 694 | $37K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 69 | $37K |
| 92540 | <1% | 457 | $37K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,702 | $37K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 130 | $30K |
| 96367 | <1% | 818 | $23K | |
| 99417 | Prolong home eval add 15m | <1% | 178 | $17K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 210 | $16K |
| 93041 | <1% | 2,833 | $9K | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | <1% | 1,236 | $9K |
| 64615 | <1% | 94 | $9K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 360 | $9K |
| 95910 | <1% | 57 | $8K | |
| 95816 | <1% | 28 | $8K | |
| 96127 | <1% | 1,749 | $7K | |
| 95700 | <1% | 25 | $4K | |
| 76376 | <1% | 62 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,311 | $3K |
| 95708 | <1% | 25 | $3K | |
| 0011A | <1% | 81 | $3K | |
| 0012A | <1% | 73 | $3K | |
| 70544 | <1% | 12 | $3K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,234 | $2K |
| 95719 | <1% | 13 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,172 | $2K |
| 96415 | <1% | 37 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 51 | $1K |
| 92546 | <1% | 12 | $894.24 | |
| 72040 | <1% | 26 | $770.68 | |
| 72100 | <1% | 25 | $736.29 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 49 | $668.04 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,071 | $615.42 |
| 72110 | <1% | 15 | $575.96 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $392.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 298 | $298.35 |
| 90785 | <1% | 14 | $160.32 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 40 | $49.49 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPALMIERO, MELISSA (CREDENTIALING SPECIALIST)